DNX-2401

Delta-24-RGD · DNAtrix

Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for DNX-2401, covering 2017-10-24 to 2026-02-20. Get the full timeline:

Most recent: Clinical Trial Update: Intratumoral DNX-2401 for High Grade Pediatric Brain Tumors [Phase 2]